Skip to content
  • News
  • Compare
  • Capital
variis
  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Events
  • Funds
  • Press
variis

Longevity intelligence for Singapore and Australia. Sourced and evidence-graded.

Directories

  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Funds
  • Events

Read

  • Archive
  • Capital
  • Compare
  • Glossary

Markets

  • Singapore
  • Australia

variis

  • About
  • Editorial standards
  • AI transparency
  • Corrections
  • Press

Legal

  • Medical disclaimer
  • Privacy policy
  • Terms of service

AI-assisted reporting, human-reviewed. Every claim sourced and graded. Not medical advice.

© 2026 variis · Singapore · Australia

  1. Home
  2. Companies
  3. ResMed

Company

ResMed

NYSE:RMD / ASX:RMD (CDIs)

Sleep/respiratory; GLP-1 screening beneficiary.

At a glance

Listing
NYSE:RMD / ASX:RMD (CDIs)
Category
Healthtech
Headquarters
San Diego (founded Sydney)
Market cap
~US$27–28B

Thesis

Why it is in this universe

Category
Healthtech
Market
Australia
Recent inflection
Acquired Noctrix Health (Jun 2026).
Services
None recorded
People tracked
2

Market data

Listing and scale

MetricDetail
ExchangeNYSE
TickerNYSE:RMD / ASX:RMD (CDIs)
Secondary listingASX
Market cap~US$27–28B
StatusListed and trading
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.

Get in touch

Contact

Address
San Diego (founded Sydney)
Website
No site on file
Phone
No public number published
Email
No public address published

Offering

What it sells today

No commercial services are recorded for this company yet.

People

Who variis tracks here (2)

variis does not publish portraits of named individuals without a licence to do so.

  • BBBaiba BrownLongevity Medicine InstituteNot a registered clinician
  • ABDr Adam BrownFounder, Longevity Medicine InstituteAs published on the clinic's own team page: "MB CHB BMedSci RCGP FRCGP (UK) FRACGP (Australia) SCCA" (Fellow, Royal College of General Practitioners UK 2011; Fellow, RACGP NSW 2018; Accredited Skin Cancer Doctor, Skin Cancer College of Australasia 2023). These are self-published qualifications, not register-confirmed.Registration published, unchecked

Recent inflection

What moved lately

Acquired Noctrix Health (Jun 2026).

Common questions

Why does variis track ResMed?
Sleep/respiratory; GLP-1 screening beneficiary.
Is ResMed publicly listed?
Yes. It trades as NYSE:NYSE:RMD / ASX:RMD (CDIs). Market capitalisation is in the ~US$27–28B range, recorded as a dated snapshot rather than a live quote.
Where is ResMed based?
San Diego (founded Sydney)
Is ResMed still trading?
ResMed is recorded as actively trading.

Keep reading

Related coverage from the newsroom.

Singapore and Australia · Capital

Singapore and Australia · Capital

Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026

Suggest an update

Sources

What this profile is built on

No source is on file for this company yet. Treat everything above as unverified until one is.

Last updated 14 August 2026

Every entity profile on variis is sourced. Not investment advice.